Genotype-Guided Antidepressant Selection: Has Precision Psychiatry Arrived? (opens in new tab)

Genetic testing to guide antidepressant selection is already being sold to the public, but the evidence is less than convincing. A new study failed to show efficacy in its primary outcome, its secondary outcomes imply a potential benefit for only 2% of patients, and it contradicts the findings of a previous study, leaving interpretation uncertain. The post appeared first on .